A detailed history of Winning Points Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Winning Points Advisors, LLC holds 15,301 shares of PFE stock, worth $420,165. This represents 0.69% of its overall portfolio holdings.

Number of Shares
15,301
Previous 15,401 0.65%
Holding current value
$420,165
Previous $789,000 20.91%
% of portfolio
0.69%
Previous 1.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $3,939 - $5,128
-100 Reduced 0.65%
15,301 $624,000
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $83 - $109
2 Added 0.01%
15,401 $789,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $41,877 - $49,653
-900 Reduced 5.52%
15,399 $807,000
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $719,373 - $891,393
-15,724 Reduced 49.1%
16,299 $844,000
Q4 2021

Feb 16, 2022

BUY
$41.32 - $61.25 $653,847 - $969,220
15,824 Added 97.69%
32,023 $1.39 Million
Q3 2021

Nov 17, 2021

BUY
$39.25 - $50.42 $80,462 - $103,361
2,050 Added 14.49%
16,199 $697,000
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $109,776 - $124,358
-3,057 Reduced 17.77%
14,149 $554,000
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $11,286 - $12,728
337 Added 2.0%
17,206 $623,000
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $303,706 - $386,189
-9,074 Reduced 34.98%
16,869 $620,000
Q2 2020

Aug 18, 2020

SELL
$30.12 - $36.54 $6,024 - $7,308
-200 Reduced 0.77%
25,943 $848,000
Q1 2020

Apr 14, 2020

SELL
$27.03 - $38.62 $140,015 - $200,051
-5,180 Reduced 16.54%
26,143 $853,000
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $6,584 - $7,472
-200 Reduced 0.63%
31,323 $1.23 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $16,245 - $21,065
-500 Reduced 1.56%
31,523 $1.14 Million
Q2 2019

Nov 12, 2019

SELL
$36.98 - $41.52 $4,067 - $4,567
-110 Reduced 0.34%
32,023 $1.39 Million
Q1 2019

Nov 14, 2019

BUY
$37.5 - $41.2 $4,500 - $4,944
120 Added 0.37%
32,133 $1.37 Million
Q4 2018

Nov 12, 2019

BUY
$38.47 - $43.86 $7,694 - $8,772
200 Added 0.63%
32,013 $1.39 Million
Q2 2018

Nov 12, 2019

SELL
$32.98 - $35.16 $46,171 - $49,223
-1,400 Reduced 4.22%
31,813 $1.15 Million
Q1 2018

Nov 12, 2019

BUY
$31.91 - $37.02 $25,528 - $29,616
800 Added 2.47%
33,213 $1.16 Million
Q4 2017

Nov 12, 2019

SELL
$33.26 - $35.29 $4,656 - $4,940
-140 Reduced 0.43%
32,413 $1.17 Million
Q3 2017

Nov 12, 2019

BUY
$31.0 - $34.15 $32,240 - $35,516
1,040 Added 3.3%
32,553 $1.16 Million
Q2 2017

Nov 08, 2019

SELL
N/A
-2,800 Reduced 8.16%
31,513 $1.07 Million
Q1 2017

Nov 08, 2019

SELL
N/A
-656 Reduced 1.88%
34,313 $1.17 Million
Q4 2016

Nov 07, 2019

BUY
N/A
34,969
34,969 $1.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Winning Points Advisors, LLC Portfolio

Follow Winning Points Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winning Points Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winning Points Advisors, LLC with notifications on news.